It is a pharma public limited company based in Kolkata, West Bengal, India, established in 2011.
2011 | Kolkata, West Bengal, India | ActivePyra Pharmaceutical Limited, a active public limited company, was established on 23 July 2011 in Kolkata, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24232WB2011PLC165248. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Subir Choudhury (Director), Ayush Poddar (Director), Sailesh Sahal (Director). Past directors included Sailesh Sahal, Devashish Poddar. Its latest AGM occurred on 13 September 2025, with the balance sheet filed on 31 March 2025. It is based at 18, Rabindra Sarani Poddar Court, Gate No 1, 9Th Floor, Kolkata, West Bengal, 700001.
U24232WB2011PLC165248
165248
23 July 2011
₹1.00 M
₹0.50 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Pyra Pharmaceutical Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subir Choudhury | Director | 23 Jul 2011 | Current |
| Ayush Poddar | Director | 23 Jul 2011 | Current |
| Sailesh Sahal | Director | 13 Aug 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 14 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pyra Pharmaceutical Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Pyra Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Pyra Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pyra Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pyra Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Pyra Pharmaceutical Limited last Annual general meeting of members was held on 13 Sep 2025 as per latest MCA records. was completed.
Progress on Pyra Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata. was documented.
Sailesh Sahal was appointed as a Director was appointed as a Director on 13 Aug 2018 & has been associated with this company since 7 years 5 months . was recorded as a recent event.
The activity Subir Choudhury was appointed as a Director was appointed as a Director on 23 Jul 2011 & has been associated with this company since 14 years 5 months . was completed.
The activity Ayush Poddar was appointed as a Director was appointed as a Director on 23 Jul 2011 & has been associated with this company since 14 years 5 months . was completed.
Pyra Pharmaceutical Limited was registered on 23 Jul 2011 with Roc Kolkata & aged 14 years 5 months as per MCA records. was recorded as a recent event.
The CIN of Pyra Pharmaceutical Limited is U24232WB2011PLC165248.
Pyra Pharmaceutical Limited is headquartered at 18, Rabindra Sarani Poddar Court, Gate No 1, 9Th Floor, Kolkata, West Bengal, 700001.
Pyra Pharmaceutical Limited was incorporated on 23 July 2011.
The current directors of Pyra Pharmaceutical Limited are
The primary industry of Pyra Pharmaceutical Limited is Pharma.
Pyra Pharmaceutical Limited is unlisted.
The authorized capital of Pyra Pharmaceutical Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Pyra Pharmaceutical Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX